Melatonin Reduces IL-33 and TSLP Expression in HNEpCs by Scavenging ROS Directly

guoxi zheng,Min-jie Gong,Hai-bao Zhang,Miao Lou,Yu-sheng Wang,Rui-ping Ma,Zhen-zhen Hu,Ya Zhang
DOI: https://doi.org/10.21203/rs.3.rs-1292062/v1
2022-02-04
Abstract:Abstract Chronic rhinosinusitis is a chronic mucosal inflammation of the nasal cavity and sinuses. It is classified into CRS without nasal polyps (CRSsNP) and CRS with nasal polyps (CRSwNP). CRSwNP has high recurrence, especially CRSwNP with massive eosinophil infiltration(ECRSwNP) which is mediated by type 2 inflammatory response. ECRSwNP is a serious problem for patients because of its easy recurrence and poor response to hormonal treatment. Melatonin has been widely studied for its powerful antioxidant and anti-inflammatory effects. In this study, we used melatonin to treat a cell model of chronic rhinosinusitis. Subsequently, MTT assay was performed to examine the cell viability of HNEpCs, a ROS kit to detect ROS production, an MDA kit to detect the MDA content in the cell culture supernatant, and an apoptosis kit and Western blotting to detect apoptosis. The expressions of Nrf2, HO-1, IL-33, TSLP, and IL-25 were detected by Western blotting. Melatonin improved the viability of HNEpCs, reversed LPS-induced ROS, reduced the MDA content, and inhibited their apoptosis. More importantly, melatonin reduced the expression of IL-33 and TSLP, an important phenomenon for the treatment of CRSwNP. This study provides preliminary evidence for using melatonin therapy to treat chronic rhinosinusitis.
What problem does this paper attempt to address?